Cancer patients with blood clots gain no benefit from inferior vena cava filter (IVCF) placement to the anticoagulant medication fondaparinux, finds research.
Deep Vein Thrombosis (DVT) - Causes - Symptoms - Diagnosis - Treatment - Complications - Prevention
A blood clot (thrombus) in the deep venous system of the leg leads to deep vein thrombosis (DVT). DVT is a major cause of morbidity and mortality.
A blood clot (thrombus) in the deep venous system of the leg leads to deep vein thrombosis (DVT). DVT is a major cause of morbidity and mortality.
The median survival for patients receiving only fondaparinux was 493 days, compared with 266 days for patients on fondaparinux plus an IVCF. Meanwhile, a median 52% of patients on fondaparinux alone experienced a complete resolution of VTEs, compared with 45% of patients on fondaparinux plus IVCF.
The study suggests that there is no benefit from costly and invasive IVCF placement in patients who are receiving fondaparinux. The results also support future randomized trials to compare VTE resolution rates achieved with fondaparinux with low molecular weight heparin, another class of anticoagulant medication.
Quiz on Cancer
Cancer, is the second most leading cause of death worldwide. Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Take this quiz on and test how much you know about cancer.
Cancer, is the second most leading cause of death worldwide. Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Take this quiz on and test how much you know about cancer.
Fondaparinux
This medication is an anticoagulant or a blood thinner, prescribed for treatment of pulmonary embolism and prevention and treatment of deep vein thrombosis. It prevents clotting of blood. It is used along with warfarin for treatment of deep vein thrombosis and pulmonary embolism.
This medication is an anticoagulant or a blood thinner, prescribed for treatment of pulmonary embolism and prevention and treatment of deep vein thrombosis. It prevents clotting of blood. It is used along with warfarin for treatment of deep vein thrombosis and pulmonary embolism.
High Risk of Blood Clots in Lungs Likely in Women Sitting for Long Periods
A study found women who sit for long periods of time everyday are two to three times more likely to develop a life-threatening blood clot in their lungs than more active women.
A study found women who sit for long periods of time everyday are two to three times more likely to develop a life-threatening blood clot in their lungs than more active women.
